Citations

ABANI, O. et al. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. The Lancet, [s. l.], v. 400, n. 10349, p. 359–368, 2022. DOI 10.1016/S0140-6736(22)01109-6. Disponível em: https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edo&AN=ejs61830955&authtype=uid&user=rmabrowserextension&password=Br0wserExtension789! Acesso em: 6 jun. 2023.

Abani O, Abbas A, Abbas F, et al. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. The Lancet. 2022;400(10349):359-368. doi:10.1016/S0140-6736(22)01109-6

Abani, O., Abbas, A., Abbas, F., Abbas, J., Abbas, K., Abbas, M., Abbasi, S., Abbass, H., Abbott, A., Abbott, A., Abdallah, N., Abdelaziz, A., Abdelaziz, A., Abdelfattah, M., Abdelqader, B., Abdul, A., Abdul, B., Abdul, S., Abdul Rasheed, A., … Zuriaga-Alvaro, A. (2022). Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. The Lancet, 400(10349), 359–368. https://doi.org/10.1016/S0140-6736(22)01109-6

Abani, Obbina, Ali Abbas, Fatima Abbas, Joshua Abbas, Kasim Abbas, Mustafa Abbas, Sadia Abbasi, et al. 2022. “Baricitinib in Patients Admitted to Hospital with COVID-19 (RECOVERY): A Randomised, Controlled, Open-Label, Platform Trial and Updated Meta-Analysis.” The Lancet 400 (10349): 359–68. doi:10.1016/S0140-6736(22)01109-6.

Abani, O. et al. (2022) ‘Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis’, The Lancet, 400(10349), pp. 359–368. doi:10.1016/S0140-6736(22)01109-6.

Abani, O, Abbas, A, Abbas, F, Abbas, J, Abbas, K, Abbas, M, Abbasi, S, Abbass, H, Abbott, Alfie, Abbott, Alison, Abdallah, N, Abdelaziz, Ammar, Abdelaziz, Ashraf, Abdelfattah, M, Abdelqader, B, Abdul, A, Abdul, B, Abdul, S, Abdul Rasheed, A, Abdulakeem, A, Abdul-Kadir, R, Abdullah, A, Abdulmumeen, A, Abdul-Raheem, R, Abdulshukkoor, N, Abdusamad, K, Abed El Khaleq, Y, Abedalla, M, Ul Amna, A, Abel, L, Abernethy, K, Abeywickrema, M, Abhinaya, C, Abidin, A, Aboaba, A, Aboagye-Odei, A, Aboelela, H, Abo-Leyah, H, Abouelela, K, Abou-Haggar, A, Abouibrahim, M, Abousamra, A, Abouzaid, M, Abraham, M, Abraham, T, Abraheem, A, Abrams, J, Abrams, R, Abu, H-J, Abu-Arafeh, A, Abubacker, SM, Abung, A, Abusamra, Y, Aceampong, Y, Achara, A, Acharya, D, Acheampong, P, Acheampong, S, Acheson, J, Achieng, S, Acosta, A, Acquah, R, Acton, C, Adabie-Ankrah, J, Adair, P, Adam, F, Adam, M, Adamali, H, Adamczyk, M, Adams, Carol, Adams, Charlotte, Adams, D, Adams, K, Adams, L, Adams, N, Adams, R, Adams, T, Adamu-Ikeme, L, Adatia, K, Adcock, K, Addo, A, Adeagbo, O, Adebiyi, A, Adedeji, O, Adegeye, Y, Adegoke, K, Adell, V, Adenwalla, S, Adeoye, FW, Adesemoye, OA, Adewunmi, EO, Adeyanju, A, Adeyemi, J, Adeyemo, T, Adhikari, B, Adhikary, R, Aditya, A, Adkins, G, Adnan, A, et al. 2022, ‘Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis’, The Lancet, vol. 400, no. 10349, pp. 359–368, viewed 6 June 2023, .

Abani, Obbina, et al. “Baricitinib in Patients Admitted to Hospital with COVID-19 (RECOVERY): A Randomised, Controlled, Open-Label, Platform Trial and Updated Meta-Analysis.” The Lancet, vol. 400, no. 10349, July 2022, pp. 359–68. EBSCOhost, https://doi.org/10.1016/S0140-6736(22)01109-6.

Abani, Obbina, Ali Abbas, Fatima Abbas, Joshua Abbas, Kasim Abbas, Mustafa Abbas, Sadia Abbasi, et al. “Baricitinib in Patients Admitted to Hospital with COVID-19 (RECOVERY): A Randomised, Controlled, Open-Label, Platform Trial and Updated Meta-Analysis.” The Lancet 400, no. 10349 (July 30, 2022): 359–68. doi:10.1016/S0140-6736(22)01109-6.

Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, et al. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. The Lancet [Internet]. 2022 Jul 30 [cited 2023 Jun 6];400(10349):359–68. Available from: https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edo&AN=ejs61830955&authtype=uid&user=rmabrowserextension&password=Br0wserExtension789!